Home > Articles > Published articles > Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case- Control (MCC) Study |
Date: | 2017 |
Abstract: | Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3. 65, 95% CI 2. 26 to 5. 91). The genetic risk score had an area under the ROC curve (AUROC) of 0. 66 (95% CI 0. 63 to 0. 68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0. 05, reaching 0. 71 (95% CI 0. 69 to 0. 74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model. |
Grants: | European Commission COST/BM1206 European Commission 036224 Agència de Gestió d'Ajuts Universitaris i de Recerca 2014-SGR-647 Instituto de Salud Carlos III PI08/1770 Instituto de Salud Carlos III PI08/0533 Instituto de Salud Carlos III PI08/1359 Instituto de Salud Carlos III PI09/00773 Instituto de Salud Carlos III PI09/01286 Instituto de Salud Carlos III PI09/01903 Instituto de Salud Carlos III PI09/02078 Instituto de Salud Carlos III PI09/01662 Instituto de Salud Carlos III PI11/01403 Instituto de Salud Carlos III PI11/01889 Instituto de Salud Carlos III PI11/00226 Instituto de Salud Carlos III PI11/01810 Instituto de Salud Carlos III PI11/02213 Instituto de Salud Carlos III PI12/00488 Instituto de Salud Carlos III PI12/00265 Instituto de Salud Carlos III PI12/01270 Instituto de Salud Carlos III PI12/00715 Instituto de Salud Carlos III PI12/00150 Instituto de Salud Carlos III PI14/01219 Instituto de Salud Carlos III PI14/00613 Instituto de Salud Carlos III PI15/00069 |
Note: | Altres ajuts: Fundación Marqués de Valdecilla (API 10/09); Junta de Castilla y León (LE22A10-2); Consejería de Salud de la Junta de Andalucía (2009-S0143); Conselleria de Sanitat de la Generalitat Valenciana (AP 061/10); Recercaixa (2010ACUP 00310); Gobierno Vasco; Consejería de Sanidad de la Región de Murcia; Fundación científica de la Asociacion Española Contra el Cáncer; Fundación Caja de Ahorros de Asturias; Universidad de Oviedo; Societat Catalana de Digestologia. |
Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Language: | Anglès |
Document: | Article ; recerca ; Versió publicada |
Published in: | Scientific reports, Vol. 7 Núm. 8994 (august 2017) , p. 1-10, ISSN 2045-2322 |
10 p, 1.4 MB |